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Diet is a key lever for microbiota-target-
ing strategies.
The gut microbiota is a source of
numerous bioactive molecules.
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ment of preventive strategies for
host–microbe dysbiosis.
The knowledge of a subject's micro-
biota can help to optimise dietary
intervention.
Diet customisation is a prerequisite for
maximal beneﬁcial effects.
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The spread of the Western lifestyle has been accompanied by microbial
changes thought to underlie the emergence of chronic, nontransmissible,
immune-related diseases. The past decade has seen the unprecedented devel-
opment of therapies for ‘replenishing’ the microbiota of sick individuals. How-
ever, functional and ecological solutions helping the host and the gut microbiota
to cope with the ecological stressors of modern life are still lacking. In this
review, we discuss how recent advances in gut microbiome science are leading
to the identiﬁcation of microbe-derived and health-relevant metabolites. These
molecules will guide the selection of the next [38_TD$DIFF]-generation of probiotics and
dietary recommendations, which should also take the resident gut microbiota
into account, to optimise efﬁcacy. These solutions for maintaining a well-func-
tioning gut ecosystem and promoting good health should be customised,
palatable, and as widely accessible as possible.Next-generation probiotics should be
selected for their ability to complement
gut microbiome deﬁciencies.
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Humans have co-evolved with their gut microbiota for millions of years, but this symbiosis is now
jeopardised by unprecedented changes in human lifestyle and environment. Antibiotic use, diets
poor in microbiota-accessible carbohydrates, excessive sanitation and birth by Caesarean
section are known to have profound effects on the gut microbiota [1]. Even unanticipated
factors, such as environmental temperatures or circadian rhythms, are now thought to contrib-
ute to contemporary changes in the Homo sapiens gut microbiota [2,3]. The concomitant
emergence in Western countries of chronic, noncommunicable diseases, such as inﬂammatory
bowel diseases (IBD), irritable bowel syndrome (IBS), cancer, diabetes and asthma [1], led the
suggestions that the disruption of human [16_TD$DIFF]–microbe symbiosis might be contributing to the
emergence of these diseases. Evidence supporting this hypothesis is now emerging and is
fuelling the combined efforts of the academic and private sectors to target the microbiota with
the aim of preventing or curing diseases.
In this review, we discuss the importance of diet as a factor contributing to host–microbe
symbiosis, by driving the production of gut microbe-derived bioactive metabolites. We also
discuss how the microbiota can be used to predict the response to dietary intervention and the
need to select a new generation of probiotics able to complement the functional deﬁciencies of
the gut microbiota and to customize dietary recommendations according to the gut microbiota
of the individual.
Dietary Changes [39_TD$DIFF]during the Course of Human Evolution
Human evolution has been accompanied by periodic fundamental changes in lifestyle reﬂected
in dietary habits. Humans were nomadic hunter-gatherers during the Palaeolithic period or Old
Stone Age, which began 2million years ago. A profound shift in human lifestyle occurred with the
Agricultural Revolution of the Neolithic period, also known as the New Stone Age (10 000 years
BC). During this period, humans began to lead a sedentary life, domesticating various animalsTrends in Microbiology, Month Year, Vol. xx, No. yy http://dx.doi.org/10.1016/j.tim.2016.09.011 1
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foods, such as cereals and dairy products, appeared, and population density increased [4].
The last marked shift in human dietary habits began with the Industrial Revolution, less than
200 years ago, which marked the start of a radical shift away from local and seasonal foods.
The modern diet is characterised by a high intake of animal products and sugars, the use
of preservatives, and a low intake of plant-based foods, such as fruits, vegetables, and
wholegrain cereals [4].
Many recent studies have focused on the co-evolution of microbial species with their hosts and
have examined the impact of westernisation on the gut microbiota, by proﬁling the gut micro-
biota in traditional human populations that have not yet adopted a Western lifestyle. The
traditional practices of these populations, from Africa, South America, and Asia, probably
resemble our own ancient lifestyles. Studies of these populations can help us to determine
the effects of lifestyle (hunting and gathering as in the Palaeolithic Period, or agriculture as in the
Neolithic Period) on the co-evolution of humans and their gut microbiota. By characterising
features of microbial adaptation to profound changes in human diet, we may be able to identify
factors underlying modern diseases and increase our understanding of the evolution and
adaptation of microbiota throughout human history [5].
The traditional populations studied have consisted of individuals from single tribes, such as
hunter-gatherers from Hazda [6,7], adults and children from Malawi [8], children from Burkina
Faso [9], Papua New Guineans [10], and Amerindians [11]. Alternatively, some studies have
focused on two tribes with contrasting [40_TD$DIFF] lifestyles (hunter-gatherer versus agricultural) [13_TD$DIFF], in Peru [12]
and Central Africa [13], for example. Modern diets contain much less ﬁbre and much more fat
than ancient diets [14]. Daily ﬁbre intakes in ancient diets could reach 100 g [15], mostly in the
form of soluble ﬁbre [16], whereas adults in industrialised countries typically eat only 15 g of ﬁbre,
falling short of the recommended daily intake of 20–30 g,mostly in the form of insoluble ﬁbre [16].
People in rural Africa may consume from 60 to 120 g ﬁbre per day [16]. Fat accounts for more
than 30% of total calories in theWestern diet, but less than 20% in rural African diets [14]. One of
the consequence of ﬁbre depletion is a decrease in short-chain fatty acid production, potentially
favouring the establishment of Enterobacteriaceae [9].
Several key consensus ﬁndings have emerged from these studies. The microbiota is more
diverse structurally and functionally (with enhanced polysaccharide breakdown capacities, in
particular) in rural and remote populations from developing countries than in urban industrialised
populations. Some bacterial taxa or functions may have disappeared from the gut during
westernisation [17]. The taxa probably lost include Treponema, a genus of anaerobic bacteria
from the phylum Spirochaetae highly specialised in the degradation of recalcitrant ﬁbre [18]. A
loss of taxa and diversity through poor diet has been experimentally demonstrated in mice. Mice
with a human gut microbiota fed a low-ﬁbre diet display a loss of gut microbial diversity over
several generations [19].
Towards the Replenishment of the Gut Microbiota [41_TD$DIFF]with Missing Functions
The past decade has seen the unprecedented emergence of new tools (DNA and RNA
sequencing, metabolomics, gnotobiology, and in vitro gut models) for exploring the molecular
events linking gut microbes to host health. Concerted efforts are currently being made to
identify molecules produced by the gut microbiota that ultimately affect host metabolic,
immune, or neuronal pathways (Figure 1). Identiﬁcation of the metabolic pathways responsible
for producing thesemolecules wouldmake it possible to develop strategies for complementing
missing functions in the microbiota or inhibiting pathways overproducing deleterious mole-
cules. We will review the metabolites demonstrated or strongly suspected to have a relevant
impact on the host.2 Trends in Microbiology, Month Year, Vol. xx, No. yy
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Figure 1. Targets for Microbiota-Based Solutions to Aid Human[16_TD$DIFF]–Microbe Symbiosis[1_TD$DIFF]. The gut microbiota is a source of a wide range of bioactive molecules,
converted from the diet and host substrates, that participate in host signalling and metabolism [17_TD$DIFF]. Dietary and host-derived factors set luminal conditions (redox, pH,
carbohydrate and electron acceptor availability) that are important in shaping the gut microbiota. Abbreviations: AHR, aryl-hydrocarbon receptor; GABA, gamma-
aminobutyric acid; TMA, trimethylamine; CLA, conjugated linoleic acids.Metabolites [42_TD$DIFF]Produced by [43_TD$DIFF]Microbes
Short-Chain Fatty Acids
Undigested dietary components (principally ﬁbres) reach the colon, where they are fermented by
the gut microbiota and converted into short-chain fatty acids (SCFAs), mostly acetate, propio-
nate, and butyrate. The host cells use these SCFAs as signalling molecules or substrates [20].
Butyrate has been shown to play a key role in gut physiology, as a major carbon source for
colonocytes, regulating critical functions of the intestine, such as intestinal motility, mucus
production, visceral sensitivity, the epithelial barrier, immune homeostasis and the mucosal
oxygen gradient [21]. The effects of SCFAs on host cells are well documented and involve G
protein-coupled protein receptors–GPR43, GPR41, and GPR109A (also known as: FFAR2,
FFAR3, and NIACR1, respectively)–and histone deacetylases (HDAC), which regulate the
transcription of genes potentially involved in immune and metabolic diseases [20,22,23].
Beyond their role in host health, SCFAs affect gut microbiota functioning. For example, a low
luminal pH favours butyrate production and inhibits gram-negative pathogens [24,25], and foods
that decrease luminal pH (ﬁbres, lactic acid bacteria or Biﬁdobacterium) have been shown to
stimulate butyrate production [25,26]. Luminal pH should, therefore, be considered a relevant
target for treatments or dietary recommendations aiming to modulate gut microbiota
functioning.Trends in Microbiology, Month Year, Vol. xx, No. yy 3
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Menaquinone, folate, cobalamin, and riboﬂavin are produced by gut microbes to fulﬁl their own
energetic and metabolic requirements. From the host perspective, these molecules act as
vitamins (vitamins K, B9, B12, and B2, respectively). Vitamin K plays a key role in blood
coagulation, bone metabolism, and, possibly, insulin sensitivity [27]. Broad-range antibiotic
treatments decrease hepatic vitamin K2 concentrations, suggesting that the gut microbiota is a
signiﬁcant source of vitamin K [28]. Vitamin B9 is an essential vitamin involved in cell division, and
a deﬁciency of this vitamin is associated with higher risks of cancer, anaemia, and neural tube
defects during embryogenesis [29]. Vitamin B12 is a metabolic cofactor, deﬁciencies of which
led to an increase in the risks of dementia in the elderly and cardiovascular disease [30,31].
Vitamin B2 is a precursor for the cofactors ﬂavin adenine dinucleotide (FAD) and ﬂavin mono-
nucleotide (FMN). Its deﬁciency is associated with neuromuscular and neurological disorders,
cancer and predisposition to Listeria infection [32,33].
The bacterial genes required for vitamin production are now well documented [34]. It should
therefore be possible to explore the role of the gut microbiota and probiotics as vitamin suppliers
in more detail.
Dietary Metabolites Transformed by Microbes
Phytoestrogens
Isoﬂavones, lignans, and ellagitannins are plant polyphenols that can be ‘bioactivated’ by gut
microbes to form equol, enterolignans (enterolactone or enterodiol), and urolithins, respectively
[35]. These bioactivated products are collectively called phytoestrogens as they can bind to
oestrogen receptors (ER-alpha and/or ER beta) [36,37]. This binding may underlie their protec-
tive effects against breast and prostate cancers [35]. Polyphenol consumption is also associated
with protection against metabolic syndrome [38], the decline of cognitive function associated
with neurological diseases [39], and cardiovascular disease [40]. The capacity of the gut
microbiota to bioactivate dietary polyphenols varies considerably between individuals, and
may be correlated with the protective effects of these compounds [35].
Isothiocyanates
Plants of the Brassicaceae family (also known as crucifers) are the main dietary source of
glucosinolates, the precursors of isothiocyanates. Glucosinolates are converted into isothio-
cyanates by [44_TD$DIFF]bacterial or [45_TD$DIFF]plant myrosinases, which are inactivated by cooking. The glucosinolates
present in cooked crucifers must, therefore, be converted into isothiocyanates by gut microbial
myrosinases, and the efﬁciency of this conversion varies between individuals [41]. Isothiocya-
nates induce cytoprotective proteins by activating the Keap1–Nrf2–ARE pathway [42], which
regulates the expression of genes encoding antioxidant proteins, drug-metabolising enzymes,
drug efﬂux pumps, heat shock proteins, and proteasome subunits [43]. The products of these
Nrf2-regulated genes attenuate the deleterious effects of toxic xenobiotics by limiting oxidative
stress and repairing damaged proteins. These and other mechanisms [42] are thought to
underlie the observed protective effects of crucifer consumption against cancer [44–46].
Aryl-Hydrocarbon Receptor Ligands
Crucifers are also very rich in indole-3-carbinol (I3C), which is oxidised to 3,30-diindolylmethane
(DIM) in the acidic conditions of the stomach. DIM is a potent activator of Nrf2 and the aryl-
hydrocarbon receptor ( [46_TD$DIFF]AhR) [47]. AhR is a transcription factor initially shown to bind xenobiotics,
such as dioxin, but now known to bind diverse synthetic and natural ligands [48]. AhR plays an
important role in immune homeostasis, by interfering with regulatory T cells, Th17, and innate
lymphoid cells, and regulating the production of IL-22, a cytokine important for epithelial repair
[49]. The protective effects of crucifers described above may also be at least partly mediated
by AhR. AhR ligands are obtained from the diet, or from gut microbes, which can produce them4 Trends in Microbiology, Month Year, Vol. xx, No. yy
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action of tryptophanases or tryptophan hydroxylases and decarboxylases [50–52]. A recent
study showed that the microbiota of caspase recruitment domain family member 9-deﬁcient
(CARD9–/–[36_TD$DIFF]) mice produced fewer AhR-ligands, resulting in a higher susceptibility to experimen-
tally induced colitis [53]. Thus, gut microbiota-derived AhR-ligands are biologically relevant and
play a signiﬁcant role in gut homeostasis.
Conjugated Linoleic Acids
The human colon receives about 6 to 8 g of lipids per day, mostly in the form of ω-6 fatty acids.
The gut microbiota can conjugate ω-6 to produce conjugated linoleic acids (CLAs) [54]. CLAs
increase insulin sensitivity, have anti-inﬂammatory properties, and reduce carcinogenesis,
atherosclerosis, and adiposity [55]. These health beneﬁts may result from their action on
peroxisome proliferator-activated receptors (PPAR) gamma and alpha, cyclooxygenases,
and lipoxygenases [55]. Propionibacterium, Biﬁdobacterium, Lactobacillus, and Roseburia
species produce CLA, with considerable variability between strains and between species
[54]. Genes encoding proteins involved in CLA production have recently been identiﬁed in
lactic acid bacteria [56], opening up new possibilities for (i) selecting strains with high levels of
CLA production and (ii) mining metagenomics data to explore links between microbial CLA
production and health or disease.
The ‘Fish Odour’ Molecule
Trimethylamine (TMA) is the molecule responsible for unpleasant ﬁshy odours. In humans,
dietary choline and L-carnitine are converted into TMA by the gut microbiota [57]. TMA is then
absorbed and oxidised by the liver enzyme FMO3, to generate trimethylamine-N-oxide (TMAO).
TMAO is pro-atherogenic in mice and was found to be associated with a high risk of cardio-
vascular disease in a human population in the United States [57]. Red meat, poultry, and eggs
are rich in choline and carnitine, and TMA and TMAO are together thought to constitute the
missing link between animal product consumption and atherosclerosis. Based on this hypothe-
sis, the development of a drug capable of inhibiting the bacterial synthesis of TMA, 3,3-dimethyl-
1-butanol (DMB), has already been described [58]. The targeting of the gut microbiota TMA
pathway thus appears to be a promising way of preventing cardiovascular diseases in the US
population, but the extrapolation of these ﬁndings to other dietary and geographic contexts
might require additional investigations [59].
Host Metabolites Inﬂuenced by Diet and Transformed by Microbes
Bile Salts
Primary bile acids are produced from cholesterol in the liver and are conjugated with taurine or
glycine to form bile salts. They are secreted into the gastrointestinal (GI) tract to solubilise lipids,
to facilitate their absorption. Bile salts are deconjugated by bile salt hydrolases (BSH), which are
produced by many gut microbes [60]. These microbial metabolites are further used by host cells
as signalling molecules activating the farnesoid X, pregnane X, and vitamin D receptors, the
G protein-coupled receptor TGR5 (TGR5), and cell signalling pathways (c-jun N-terminal kinase
1/2, AKT, and ERK 1/2) [61], to regulate bile acid and glucose levels, and fatty acid and
lipoprotein synthesis [61].
In addition to their effects on the host, bile salts are also known to play a role in shaping the gut
microbiota [62]. Indeed, bile salts have differential bactericidal effects: Firmicutes and Proteo-
bacteria are generally more resistant to bile salts than Bacteroides [63]. Thus, as bile salt
production increases with the consumption of a high-fat diet, Yokota et al. have suggested that
the Firmicutes/Bacteroides ratio, previously reported to be positively associated with obesity,
reﬂects high levels of food and fat intake [62]. Bilophila wadsworthia is another potential bacterial
marker of the type of fat consumed, as this pro-inﬂammatory pathobiont ﬂourishes when fats ofTrends in Microbiology, Month Year, Vol. xx, No. yy 5
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Box 1. The Renaissance of Probiotics
Probiotics have long been selected on the basis of their capacity to survive the harsh conditions of the upper digestive
tract, to adhere to epithelial cells, to inhibit pathogens, and/or their effects on epithelial, immune or neuronal cells [26,97].
Today, our increasingly extensive knowledge of new microbiota-related pathways relevant ecologically and to health, is
making it possible to re-select probiotics on the basis of the function of the gut microbiota they should complement.
Commensal organisms have considerable potential for use as new probiotics, but technological limitations (such as the
need for strict anaerobic conditions), and antibiotic resistance may restrict their use to therapeutic applications. By
contrast, lactic acid bacteria and Biﬁdobacterium are known to resist industrial process, and many studies have already
shown that they can produce bioactive compounds, such as CLAs [98], neuromediators [ [28_TD$DIFF]99], Ahr-ligands [ [29_TD$DIFF]100],
polyphenols [ [30_TD$DIFF]101], iron scavengers [ [31_TD$DIFF] 02,103], vitamins [ [32_TD$DIFF]104,105], TMA [ [33_TD$DIFF]106], SCFA [[34_TD$DIFF]107], and antioxidants [9_TD$DIFF] [35_TD$DIFF] 108].
Future studies will almost certainly identify additional functions that these bacteria can deliver. Consequently, lactic acid
bacteria and Biﬁdobacterium libraries are a source of promising candidates for next-generation probiotics.animal origin are consumed [64]. Overall, these results suggest that attention should be paid to
the quantity and quality of lipids consumed, as these molecules may have potent deleterious
effects on the structure of the gut microbiota.
These advances in our understanding of gut microbiota function can serve as the basis of novel
strategies for the complementation of gut microbiota dysfunction (Box 1).
The Microbiota Challenge: It's Not a Level Playing Ground
One Diet, Many Microbial Possibilities
Microbiota responses to dietary intervention are known to vary considerably between subjects
[65,66]. Studies of individuals with a microbiota response to a particular intervention have
provided information about the ecology of the responding microbiota. Table 1 provides a
summary of clinical studies in which the subjects were stratiﬁed for the baseline composition,
metabolite content and richness of the microbiota or the response to a given dietary inter-
vention. The interventions tested included the consumption of [47_TD$DIFF] a fermented milk [48_TD$DIFF]product (FMP)
[67]. The identiﬁcation of two distinct patterns of response to FMP ingestion (i.e. ‘permissive’
and ‘resistant’ microbiota) indicated that the live bacteria present in fermented products might
have different impacts on the host and/or microbiota according to the nature of the microbiota
present [68]. Microbiota richness has been identiﬁed as a factor controlling the extent of
microbial modulation after the consumption of speciﬁc diets for weight loss, or rich in non-
starch polysaccharides or ﬁbre [69–72]. The presence of a ‘rich’ microbiota is associated with
higher caproate and valerate concentrations and a higher Prevotella:Bacteroides ratio. The
richness of the baseline microbiota was found to be correlated with greater microbiota stability
during dietary intervention in several studies. More diverse microbial ecosystems have already
been shown to be more stable, particularly for the gut microbiota in elderly subjects [73]. This
topic has been the subject of several recent reviews [74,75]. The positive correlation between
baseline microbiota richness and stability following dietary intervention probably reﬂects a
higher level of functional redundancy in rich microbiota [74]. As shown above, subjects with
low and high microbiota richness often respond differently to dietary intervention. Differences
between individuals with high and low microbiota richnesses have been characterized in a
cohort of obese and lean individuals [76]. From an ecological perspective, low microbiota
richness is generally associated with higher abundance of members of Proteobacteria–
including oxygen tolerant species–and Bacteroidetes, whereas high microbiota richness is
associated with a high abundance of members of Firmicutes, Actinobacteria and
Verrucomicrobia.
Approaches based on the stratiﬁcation of subjects, based on the response of the microbiota,
and according to the initial state of their microbiota, have been described principally in terms of
richness, metabolites, and the abundance of particular microbial taxa, with speciﬁcally Biﬁdo-
bacterium [77–79] and recently the more global community. Based on this concept, clinical trials6 Trends in Microbiology, Month Year, Vol. xx, No. yy
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Table 1. Example Clinical Studies Using the Baseline Microbiota to Assess Microbiota or Host Responses
Following Dietary Intervention
Cohort Intervention
(type and duration)
Stratiﬁcation
based on
Microbiota response following
intervention
Refs
Microbiota responses
Overweight-
obese
(N = 49)
Calorie restriction
6 weeks
Microbiota
richness
Large increase in microbiota
richness in the low-microbiota
richness group
No change in microbiota
richness in the high-microbiota
richness group
[81]
Healthy
subjects
(N = 33)
[18_TD$DIFF]Lactobacillus
paracasei DG
(N = 14) [19_TD$DIFF]and
[20_TD$DIFF]control (N = 16)
4 weeks
Faecal butyrate
(<25 mmol/kg
of wet faeces)
Increase in butyrate, and an
increase in Ruminococcus
species and a Bacteroidales
genus in the group with low
faecal butyrate concentration
[95]
Overweight-
obese
individuals
(N = 78)
Different diets:
High ﬁbre: high-ﬁbre rye
bread and whole-grain
pasta (N = 28)
[21_TD$DIFF]Low ﬁbre (N = 24)
Inulin and oligofructose
(N = 13)
[22_TD$DIFF] our types of diet [23_TD$DIFF] as
reported below (N = 13)
10–12 weeks
Microbiota stability Lower stability of microbiota in
subjects with a lower
abundance of Eubacterium
ruminantium and Clostridium
felsineum
[70]
Change in
Biﬁdobacterium
during intervention
Higher Biﬁdobacterium levels
in subjects with lower baseline
Biﬁdobacterium levels
[70]
Obese
individuals
N = 14
Four types of diet:
Maintenance diet (1 week)
Resistant starch (3 weeks)
Non-starch polysaccharides
(3 weeks)
Weight-loss diet (3 weeks)
Microbiota modulation Microbiota responsiveness
was negatively associated with
baseline diversity
[71]
[96]
Healthy
adults
(N = 19)
Two diets with 2 doses of
dietary ﬁbre (10 or 40 g)
5 days each
Microbiota stability Greater stability of microbiota
in subjects with high baseline
microbiota richness
[72]
Healthy
women
(N = 14)
Fermented milk product (FMP)
7 weeks
Detection of
Lactococcus lactis
after the cessation
of FMP
Subjects with lower L. lactis
clearance [24_TD$DIFF]displayed greater
modulation of the gut
microbiota and have a higher
relative abundance of
Barnesiellaceae
Odoribacteraceae and
Clostridiaceae
[67]
Healthy
subjects
(N = 31)
Biscuits with partially
hydrolysed guar gum
(PHGG) and
fructooligosaccharides
21 days
Change in bacterial
groups
Subjects with low baseline
Biﬁdobacterium levels
displayed larger increases in
Biﬁdobacterium levels
following consumption of
biscuits
[79]
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Table 1. (continued)
Cohort Intervention
(type and duration)
Stratiﬁcation
based on
Microbiota response following
intervention
Refs
Clinical responses
Rome III
IBS children
(N = 12)
Low fermentable substrate
1 week
GI symptoms:
abdominal pain
frequency
Responders[3_TD$DIFF] had a higher
abundance of Sporobacter,
Subdoligranulum, and a lower
abundance of Bacteroides
[4_TD$DIFF] 97]
Rome III
IBS children
(N = 33)
Low FODMAP
2 days
GI symptoms:
abdominal
pain frequency
Responders[5_TD$DIFF] had higher levels
of Bacteroides,
Ruminococcaceae,
Faecalibacterium prausnitzii
and KEGG orthologues related
to FODMAP
carbohydrate metabolism
[85]
Overweight-
obese
(N = 49)
Calorie restriction
6 weeks
[25_TD$DIFF] nﬂammation variables Subjects with higher gene
richness [6_TD$DIFF] at baseline displayed
a greater improvement in
adipose tissue and systemic
inﬂammation variables
[81]
Overweight-
obese
(N = 49)
Calorie restriction
6 weeks
Metabolic variables Subjects with a higher baseline
level of A. muciniphila[7_TD$DIFF]
displayed a greater
improvement in insulin
sensitivity markers and other
clinical parameters
[82]
Overweight -
obese
N = 45
Calorie restriction
6 weeks
Weight reduction Individuals who lost less weight
and rapidly regained weight
during the stabilisation period
had a higher abundance of
Lactobacillus/Leuconostoc/
Pediococcus at baseline
[83]
Obese
individuals
from three
independent
cohorts
(N = 78)
Diverse dietary
interventions
Cholesterol levels Subjects with lower cholesterol
levels had a higher abundance
of C. sphenoides
[70]
Homeostasis model
assessment of insulin
resistance (HOMA)
response
HOMA response predicted by
baseline abundance of
Clostridium clusters XVI, XVIa,
bacilli and Proteobacteria
C-reactive protein C-reactive protein response
predicted by baseline
abundance of Clostridium.
Clusters VI, XI, XVIa,XVIII
Healthy
subjects
(N = 20)
High-barley diet
3 days
Glucose metabolism Subjects with a weaker
glycaemic response [26_TD$DIFF]had higher
baseline Prevotella abundance
[84]
Healthy
subjects
(N = 7)
Low-calorie artiﬁcial
sweeteners
1 week
Glycaemic response Subjects with a stronger
glycaemic response [27_TD$DIFF]had a
microbiota different from that
of other subjects
[98]
Nondiabetic
adults
(N = 800)
Standardised and
real-life meals
1 week
Glycaemic response Algorithm based on clinical and
microbiota data
[65]
8 Trends in Microbiology, Month Year, Vol. xx, No. yy
TIMI 1380 No. of Pages 13have recently been set up to determine whether baseline gut microbiota composition and
function differ between individuals with low and high dietary ﬁbre intakes [80].
Microbiota, the X-factor in Dietary Interventions
The magnitude of the response of the gut microbiota to a dietary intervention (as discussed
above) may reﬂect differences in impact on the clinical parameters of the host. Indeed, recent
studies have also stratiﬁed subjects on the basis of clinical outcome [14_TD$DIFF] (Table 1). Cotillard et al.
showed that the response of inﬂammation parameters to a 6-week low-calorie diet was stronger
in overweight/obese individuals with a high microbiota richness (60% of subjects) than in those
with a lower microbiota richness [81]. In the same cohort, Dao et al. observed that subjects with
a higher baseline level of Akkermansia muciniphila displayed a greater improvement in insulin
sensitivity markers and other clinical parameters after a low-calorie diet [82]. Subjects from the
same cohort who lost less weight during the calorie reduction phase and regained weight during
the 6-week stabilisation period had higher baseline levels of Lactobacillus/Leuconostoc/Ped-
iococcus in faecal samples, as shown by quantitative PCR [83]. Similarly, Kovatcheva et al.
reported that healthy individuals with a higher abundance of Prevotella coprii in the gut
responded better to 3 days of a diet enriched in barley than those with lower levels of this
microbe, as demonstrated by metabolic ﬁndings, such as improvements in glucose metabolism
[84]. In one study, children with IBS were fed a diet low in fermentable oligo-, di-, monosac-
charides and polyols (FODMAPs) for 2 days. Those with gut microbiota populations containing
larger numbers of taxa known to break down sugar efﬁciently (Bacteroides, Ruminococcaceae,
and Faecalibacterium prausnitzii) before the intervention experienced greater pain relief [85].
Although using the gut microbiota as an enrolment and stratiﬁcation factor seem to hold
promises, challenges remain, particularly as concerns the representativeness of a single stool
sample collected at one time point, given the between-day or even within-day variability of the
faecal microbiota [2]. This issue is of particular importance in subjects displaying larger micro-
biota ﬂuctuations, such as those with a lower microbiota richness, diseases such as IBD [86],
infections, travel, or on antibiotics [87,88]. An understanding of natural between- and within-day
variability and the collection of clinical data will be crucial in future clinical studies.
From Apple® to Apples: From Big Data to Tailored Nutrition
As discussed above, the same diet can have different impacts in different hosts and on different
microbiota. Thus, one of the future challenges in the ﬁeld of nutrition will be to personalise
nutrition, taking into account the gut microbiota, host genetics, and environmental factors
(Figure 2), to make individual-relevant dietary recommendations. In a recent study, Zeevi
et al. demonstrated the validity of this concept, by showing that personalised dietary recom-
mendations, computed from a set of host, environmental and microbial variables, lowered
postprandial glycaemic response in humans more effectively than the recommendations of
experts [65]. The plethora of smartphone applications (apps) now available makes it possible for
the general public to obtain access to tailored nutritional recommendations that seem to be
indeed effective [89].
In the future, dietary recommendations will probably also be tailored to stimulate, inhibit or
complement gut microbial functions shown to be relevant to health. In the absence of recom-
mendations, diets in which speciﬁc nutrients are restricted have recently emerged as a means of
relieving GI symptoms (Box 2). However their long-term consequences for the gut microbiota
remain unknown. The development of dietary recommendations in the future will be made
possible by (i) the increasing efforts of the scientiﬁc community to understand the effects of
gut microbial metabolites on host health, (ii) the exponential amounts of microbiota data and
metadata accumulating, fueled by pioneer self-trackers [90] and large microbiota cohorts, (iii)
falling costs of genome sequencing, which will make the generalisation of microbiota self-trackingTrends in Microbiology, Month Year, Vol. xx, No. yy 9
TIMI 1380 No. of Pages 13
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Figure 2. Dietary Recommendations Based on the Microbiota, Diet Preference, and the Metabolic and
Immune State of Individuals. In the near future, it should be possible to improve the selection of appropriate subjects for
inclusion in clinical studies, based on diet, for example, and to improve and predict clinical outcomes by taking the initial
state of the microbiota into account and identifying microbiota-based markers correlated with outcome.
Box 2. Recent Emergence of Restrictive Diets
Diets to reduce GI symptoms are becoming increasingly popular. A diet low in poorly absorbed and fermentable
carbohydrates, the so-called “low FODMAPs” (fermentable oligo-, di-, monosaccharides and polyols) diet, reduces
gastrointestinal symptoms in patients with IBS [10_TD$DIFF]. It remains unclear whether the microbiota changes related to this diet
have a long-term impact on host health, and only a few studies have addressed this issue [11_TD$DIFF]. The exclusion of gluten may
also modify the composition of the gut microbiota [12_TD$DIFF], although this aspect has yet to be studied in detail. The long-term
safety, efﬁcacy and impact on the gut microbiota of these exclusive diets require further evaluation in longitudinal
cohorts.
Outstanding Questions
What level of personalised nutrition will
be achievable in the future?
How feasible is the reintegration of tra-
ditional habits, speciﬁcally those of a
dietary nature, into modern life?
Will more widespread microbiota
assessment in the general population
help to integrate diet into strategies for
preventing dysbiosis?
Will integrative approaches based on
metabolic interactions between the
microbiota and the host be adaptable
to real-life situations?possible and, ﬁnally, (iv) the development of mathematical methods for mining big data for the gut
microbiota [91].
Concluding Remarks
Westernisation has had unexpected consequences for human health. For example, adequate
vitamin D levels in the Scottish population relied for more than 14 000 years on a tenuous
equilibrium between biological traits (i.e. maximally depigmented skin optimising vitamin D
production), sunlight exposure (i.e. outdoor activities) and dietary habits (i.e. consumption of
vitamin-D rich foods, such as cod or herring). However, the recent urbanisation of Scotland10 Trends in Microbiology, Month Year, Vol. xx, No. yy
TIMI 1380 No. of Pages 13(starting 200 years ago) was accompanied by a decrease in vitamin D-rich ﬁsh consumption
and a decrease in outdoor activities, with these two changes contributing to the disruption of the
fragile vitamin D equilibrium and leading to unprecedented levels of vitamin D deﬁciency at the
population scale [92]. This deﬁciency is thought to be a risk factor for emerging immune-related
diseases. Public health agencies therefore recommend supplementing the diet with vitamin D
and increasing exposure to daylight [92]. This example highlights how relatively recent changes
on the scale of human history can disrupt long-established equilibria controlled by genetics,
behaviour, diet, and environment. It also illustrates how an understanding of the molecular
factors at work in such equilibria (vitamin D in this example) can facilitate the design of dietary and
behavioral strategies to limit the consequences of urbanisation.
In the future, similar developments will probably emerge in the gut microbiota ﬁeld. For example,
it is nowwidely accepted that the exposure of human babies to their mothers’ vaginal microbiota
during delivery optimises early intestinal colonisation, with potential long-term beneﬁts. Clinicians
have, thus, started to swab babies delivered by Caesarean section with vaginal secretions from
the mother [93]. The real beneﬁts of this practice have yet to be assessed, but it shows that
scientists are already trying to ﬁnd ways to attenuate the effects of Western stressors on the gut
microbiota.
Dietary interventions are the most robust and attainable approach for modulating the gut
microbiota at the population scale. Public health agencies are already promoting microbiota-
sound practices, such as increasing ﬁbre consumption, decreasing meat intake and diversifying
the diet. In the future, dietary recommendations will almost certainly promote other types of food
providing factors essential for the correct functioning of the gut microbiota. As dietary recom-
mendations are known to be poorly followed by populations [94], dietary supplementation with
next-generation probiotics (Box 1) selected for their ability to deliver functions missing from the
dysbiotic gut microbiota would be very useful. The recent discovery of key gut microbiota-
derived metabolic end products will facilitate the design of this new generation of functional
foods. The more widespread use of gut microbiota proﬁling will also make it easier to identify the
individuals most likely to beneﬁt from such functional foods and dietary guidance.
In conclusion, public and private research is currently focusing on ‘resetting’ the microbiota of
individuals with disease, but we also need to ﬁnd solutions to prevent the disruption of human [16_TD$DIFF]–
microbe symbiosis. Personalised diets, supplemented with the next[38_TD$DIFF]-generation of probiotics,
will undoubtedly be a component of the preventive solutions on offer in the future (see
Outstanding Questions).
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